Express News Service NEW DELHI: Days after the government announced that 15 to 17-year-olds in India will be eligible for the Covid vaccine —...
Bharat Biotech
By PTI HYDERABAD: Bharat Biotech’s vaccine Covaxin has demonstrated that it is 77.8 per cent effective against symptomatic Covid-19, through evaluation of 130 confirmed...
By PTI NEW DELHI: The ideal time for a booster dose for COVID-19 vaccine is six months after the second dose, Bharat Biotech Chairman...
By PTI HYDERABAD: Ocugen, Bharat Biotech’s US partner for COVID-19 vaccine Covaxin, on Wednesday said it has submitted Investigational New Drug Application (IND) to...
The Hyderabad-based Bharat Biotech had applied to the WHO on April 19 for Covaxin's Emergency Use Listing (EUL).
By Express News Service NEW DELHI: The wait for emergency use listing (EUL) of COVID-19 vaccine Covaxin by the World Health Organisation is set...
By Express News Service NEW DELHI: After receiving go-ahead for Covaxin for the two-years plus population by the drug regulator’s expert panel, Bharat Biotech...
Express News Service NEW DELHI: An expert panel on Covid under the country’s apex drug regulator has approved administering Covaxin for kids and adolescents,...
By PTI NEW DELHI: An expert panel of India’s Central Drug Authority has recommended granting emergency use authorisation to Bharat Biotech’s Covaxin for children...
Express News Service BENGALURU: Bharat Biotech, the developer of the indigenously developed Covid-19 vaccine Covaxin, is said to have submitted its Phase II/III clinical...